{"id":"https://openalex.org/W2118912931","doi":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","title":"Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study","display_name":"Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study","alternate_titles":[],"publication_year":2007,"publication_date":"2007-05-03","ids":{"openalex":"https://openalex.org/W2118912931","doi":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","mag":"2118912931","pmid":"https://pubmed.ncbi.nlm.nih.gov/17441971"},"language":"en","primary_location":{"id":"doi:10.1111/j.1468-2982.2007.01326.x","doi":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","pdf_url":null,"source":{"id":"https://openalex.org/S141866484","display_name":"Cephalalgia","issn_l":"0333-1024","issn":["0333-1024","1468-2982"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cephalalgia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118912931"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114018595","display_name":"HC Diener","orcid":"https://orcid.org/0000-0002-6556-8612","observed_orcids":["https://orcid.org/0000-0002-6556-8612"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H-C Diener","raw_affiliation_strings":["Department of Neurology, University of Duisburg-Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Duisburg-Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028267184","display_name":"Gennaro Bussone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Bussone","raw_affiliation_strings":["Department of Neurology, \u2018C. Besta\u2019 Neurological Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, \u2018C. Besta\u2019 Neurological Institute, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111642661","display_name":"JC Van Oene","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JC Van Oene","raw_affiliation_strings":["Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Lahaye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Lahaye","raw_affiliation_strings":["Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091766224","display_name":"Susanne Schwalen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Schwalen","raw_affiliation_strings":["Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen-Cilag EMEA, Tilburg, the Netherlands and Neuss, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109222943","display_name":"PJ Goadsby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"PJ Goadsby","raw_affiliation_strings":["Department of Neurology, University of California, San Francisco, CA, USA","Institute of Neurology, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Institute of Neurology, London, UK","institution_ids":["https://openalex.org/I4405260083"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5109222943"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4405260083"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":27.5855,"has_fulltext":false,"cited_by_count":585,"citation_normalized_percentile":{"value":0.99835458,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"27","issue":"7","first_page":"814","last_page":"823"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10852","display_name":"Temporomandibular Joint Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3504","display_name":"Oral Surgery"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/headache-days","display_name":"headache days","score":0.6330000162124634},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8339999914169312},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.7689999938011169},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.878000020980835},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.609000027179718},{"id":"https://openalex.org/keywords/migraine-disability","display_name":"migraine disability","score":0.3160000145435333},{"id":"https://openalex.org/keywords/hit-6","display_name":"HIT-6","score":0.7419999837875366},{"id":"https://openalex.org/keywords/migraine-specific-quality-of-life-questionnaire","display_name":"Migraine-Specific Quality of Life Questionnaire","score":0.9520000219345093},{"id":"https://openalex.org/keywords/migraine-disability-assessment","display_name":"Migraine Disability Assessment","score":0.9380000233650208},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4519999921321869},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.3059999942779541},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.3070000112056732}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.9306246042251587},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.9063355326652527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.882290780544281},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7487469911575317},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6458405256271362},{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.6278375387191772},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5531538724899292},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5465596914291382},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.45560234785079956},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4198407530784607},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38357749581336975},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35773271322250366},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3288372755050659},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2802886366844177},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.21306616067886353},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.08974084258079529},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004185","descriptor_name":"Disability Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051271","descriptor_name":"Headache Disorders, Secondary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051271","descriptor_name":"Headache Disorders, Secondary","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1468-2982.2007.01326.x","doi":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1468-2982.2007.01326.x","pdf_url":null,"source":{"id":"https://openalex.org/S141866484","display_name":"Cephalalgia","issn_l":"0333-1024","issn":["0333-1024","1468-2982"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cephalalgia","raw_type":"journal-article"},{"id":"pmid:17441971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17441971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cephalalgia : an international journal of headache","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:165832","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/165832/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CEPHALALGIA , 27 (7) 814 - 823. (2007)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W168339626","https://openalex.org/W1550475500","https://openalex.org/W1958971206","https://openalex.org/W1968001773","https://openalex.org/W1968865115","https://openalex.org/W1973511428","https://openalex.org/W2009222901","https://openalex.org/W2015197538","https://openalex.org/W2022759950","https://openalex.org/W2036520094","https://openalex.org/W2059691201","https://openalex.org/W2060416301","https://openalex.org/W2062526596","https://openalex.org/W2066289781","https://openalex.org/W2083322751","https://openalex.org/W2094347820","https://openalex.org/W2098351223","https://openalex.org/W2109048238","https://openalex.org/W2109596912","https://openalex.org/W2128211840","https://openalex.org/W2135382170","https://openalex.org/W2151599925","https://openalex.org/W2158846562","https://openalex.org/W2160202859","https://openalex.org/W2166645268","https://openalex.org/W2169186856","https://openalex.org/W2331364533","https://openalex.org/W3015167373","https://openalex.org/W4245714281","https://openalex.org/W4247755222","https://openalex.org/W4252919042"],"related_works":["https://openalex.org/W2127042724","https://openalex.org/W2127880532","https://openalex.org/W2062526596","https://openalex.org/W2116941156","https://openalex.org/W2015197538","https://openalex.org/W2089559518","https://openalex.org/W2026080368","https://openalex.org/W2137434212","https://openalex.org/W3202501052"],"abstract_inverted_index":{"The":[0,162,328,417],"aim":[1],"of":[2,12,17,32,71,134,171,184,194,203,217,226,294,331,363,412,442,455,478,485],"this":[3,62],"study":[4,204],"was":[5,125,166,219,246,300,333],"to":[6,97,115,130,142,146,179],"evaluate":[7],"the":[8,15,69,108,160,167,175,180,185,189,212,222,232,238,264,305,313,320,360,395,475,483],"efficacy":[9,164],"and":[10,100,206,237,244,253,285,308,335,340,349,354,389,427,440,453,468],"tolerability":[11,245],"topiramate":[13,116,274,306,396,465],"for":[14,44,68,91,119,154,322,338,347,387,474],"prevention":[16],"chronic":[18,45,81,479],"migraine":[19,27,46,72,82,89,105,150,172,295,365],"in":[20,36,61,74,169,188,263,304,312,429,482],"a":[21,29,120,131],"randomized,":[22,459],"double-blind,":[23,460],"placebo-controlled":[24,461],"trial.":[25,123,161],"Chronic":[26],"is":[28,66,466],"common":[30,419],"form":[31],"disabling":[33],"headache":[34,37,73],"presenting":[35],"subspecialty":[38],"practice.":[39],"Preventive":[40],"treatments":[41],"are":[42,50],"essential":[43],"management,":[47],"although":[48],"there":[49],"few":[51],"or":[52,86,93,103,117],"no":[53],"controlled":[54],"empirical":[55],"trial":[56,98,255,462],"data":[57],"on":[58],"their":[59],"use":[60],"patient":[63,147],"population.":[64],"Topiramate":[65,124,357],"approved":[67],"prophylaxis":[70],"adults.":[75],"Patients":[76],"(18-65":[77],"years)":[78],"who":[79,197],"experienced":[80],"(defined":[83],"as":[84],">":[85,92,102],"=15":[87],"monthly":[88,364],"days)":[90],"=3":[94],"months":[95],"prior":[96],"entry":[99],"had":[101,207],"=12":[104],"days":[106,173,183,296,337,366],"during":[107,211],"4-week":[109],"(28-day)":[110],"baseline":[111,177,292],"phase":[112,178,187],"were":[113,157,259,352,385,408,431],"randomized":[114],"placebo":[118,314,374],"16-week,":[121],"double-blind":[122,186,213],"titrated":[126],"(25":[127],"mg":[128],"weekly)":[129],"target":[132],"dose":[133,202,277],"100":[135,281,334],"mg/day,":[136,144],"allowing":[137],"dosing":[138],"flexibility":[139],"from":[140,174],"50":[141],"200":[143],"according":[145],"need.":[148],"Existing":[149],"preventive":[151,476],"treatments,":[152],"except":[153],"antiepileptic":[155],"drugs,":[156],"continued":[158],"throughout":[159],"primary":[163],"measure":[165],"change":[168],"number":[170,293,362],"28-day":[176],"last":[181],"28":[182],"intent-to-treat":[190,265],"population,":[191],"which":[192],"consisted":[193],"all":[195],"patients":[196,258,262,287,317,351,414],"received":[198,273,288],"at":[199,326],"least":[200],"one":[201,208],"medication":[205,324,486],"outcome":[209],"assessment":[210],"phase.":[214],"Health-related":[215],"quality":[216],"life":[218],"evaluated":[220],"with":[221,373,394],"Migraine":[223,239],"Specific":[224],"Quality":[225],"Life":[227],"Questionnaire":[228],"(MSQ,":[229],"Version":[230],"2.1),":[231],"Headache":[233],"Impact":[234],"Test":[235],"(HIT-6)":[236],"Disability":[240],"Assessment":[241],"(MIDAS)":[242],"questionnaires,":[243],"assessed":[247],"by":[248,368,410,433],"adverse":[249,406],"event":[250],"(AE)":[251],"reports":[252],"early":[254],"discontinuations.":[256],"Eighty-two":[257],"screened.":[260],"Thirty-two":[261],"population":[266],"(mean":[267,275],"age":[268],"46":[269],"years;":[270],"75%":[271,353,411],"female)":[272],"modal":[276],"+/-":[278,282,302,310,370,376],"SD":[279],"=":[280,400],"17":[283],"mg/day)":[284],"27":[286],"placebo.":[289],"Mean":[290],"(+/-SD)":[291,367],"per":[297],"4":[298],"weeks":[299],"15.5":[301],"4.6":[303],"group":[307,398],"16.4":[309],"4.4":[311],"group.":[315],"Most":[316],"(78%)":[318],"met":[319],"definition":[321],"acute":[323],"overuse":[325],"baseline.":[327],"mean":[329,361],"duration":[330],"treatment":[332,397,477],"92":[336],"topiramate-":[339,348],"placebo-treated":[341,350,456],"patients,":[342,444],"respectively.":[343,356],"Study":[344],"completion":[345],"rates":[346],"52%,":[355],"significantly":[358],"reduced":[359],"3.5":[369],"6.3,":[371],"compared":[372],"(-0.2":[375],"4.7,":[377],"P":[378],"<":[379],"0.05).":[380],"No":[381],"significant":[382],"intergroup":[383],"differences":[384],"found":[386],"MSQ":[388],"HIT-6.":[390],"MIDAS":[391],"showed":[392],"improvement":[393],"(P":[399],"0.042":[401],"vs.":[402,446],"placebo).":[403,416],"Treatment":[404],"emergent":[405],"events":[407],"reported":[409,432],"topiramate-treated":[413,443],"(37%,":[415],"most":[418],"AEs,":[420],"paraesthesia,":[421],"nausea,":[422],"dizziness,":[423],"dyspepsia,":[424],"fatigue,":[425],"anorexia":[426],"disturbance":[428],"attention,":[430],"53%,":[434],"9%,":[435],"6%,":[436,437,438],"6%":[439,441],"respectively,":[445],"7%,":[447],"0%,":[448,449,450,451],"4%":[452,454],"patients.":[457],"This":[458],"demonstrates":[463],"that":[464],"effective":[467],"reasonably":[469],"well":[470],"tolerated":[471],"when":[472],"used":[473],"migraine,":[480],"even":[481],"presence":[484],"overuse.":[487]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118912931","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":34},{"year":2020,"cited_by_count":35},{"year":2019,"cited_by_count":32},{"year":2018,"cited_by_count":44},{"year":2017,"cited_by_count":23},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":31},{"year":2014,"cited_by_count":31},{"year":2013,"cited_by_count":26},{"year":2012,"cited_by_count":31}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
